{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:33:40Z","timestamp":1767008020578,"version":"3.48.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite preclinical evidence for berberine's antidepressant potential, its pharmacological effects remain controversial.This study therefore systematically reviews animal research to clarify its mechanisms and support future clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Web of Science, Cochrane Library, and OVID for studies on berberine in depression models up to March 20, 2025. Analysis used STATA 15.0 and Review Manager 5.4, with study quality assessed via SYRCLE's risk of bias tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The meta-analysis included 18 studies (338animals). Overall, berberine significantly reduced depression-like behaviors in animal models.Specifically, BBR increased total locomotor activity in the open field test (SMD=2.79, 95% CI: 1.55, 4.02) and time spent in the center zone (SMD=2.49, 95% CI:1.61, 3.37), reduced immobility time in both the forced swim test and tail suspension test (SMD =-4.42, 95% CI:-5.77,-3.07; SMD=-4.46, 95% CI:-6.21, -2.71), increased sucrose intake in the sucrose preference test (SMD = 3.72, 95% CI: 2.37, 5.07), and reduced feeding latency in the novelty-suppressed feeding test (SMD=-5.72, 95% CI:-7.63, -3.82). However, BBR did not significantly alter the number of square crossings (SMD=1.36, 95%CI:-0.07 , 2.79) or rearing frequency (SMD=1.66, 95% CI: -0.29, 3.61) in the open field test. BBR also increased the levels of body weight, brain-derived neurotrophic factor, dopamine, serotonin, and norepinephrine,while reducing the levels of pro-inflammatory cytokines including TNF-\u03b1, IL-1\u03b2, and IL-6.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Preclinical studies suggest that berberine may represent a promising therapeutic agent for the treatment of depressive disorders. Its antidepressant effects appear to be closely associated with the modulation of neurotransmitter levels,reduction of oxidative stress, and inhibition of inflammatory responses.However, methodological limitations may constrain these findings. Larger, more rigorous preclinical studies are needed for confirmation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/inplasy.com\/inplasy-2025-6-0002<\/jats:ext-link>\n                      , identifier INPLASY202560002.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1653929","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:24:14Z","timestamp":1767007454000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The effects of berberine on depressive symptoms: a systematic review and meta-analysis of preclinical studies"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaona","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengqun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a Lancet; World Psychiatric Association Commission","volume":"399","author":"Herrman","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(19)31151-1","article-title":"Depression","volume":"393","author":"Vos","year":"2019","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230025","article-title":"Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape","volume":"180","author":"Jha","year":"2023","journal-title":"Am J Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22969","article-title":"Antidepressant medications and weight change: A narrative review","volume":"28","author":"Gill","year":"2020","journal-title":"Obes (Silver Spring)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50522","article-title":"Antidepressant-induced sexual dysfunction","volume":"212","author":"Rothmore","year":"2020","journal-title":"Med J Aust"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110266","DOI":"10.1016\/j.pnpbp.2021.110266","article-title":"Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis","volume":"109","author":"Oliva","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000447034","article-title":"The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature","volume":"85","author":"Carvalho","year":"2016","journal-title":"Psychother Psychosom"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1331440","article-title":"Research progress on antidepressant effects and mechanisms of berberine","volume":"15","author":"Gao","year":"2024","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1015045","article-title":"Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2003176","DOI":"10.1080\/19490976.2021.2003176","article-title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study","volume":"14","author":"Wang","year":"2022","journal-title":"Gut Microbes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/1389557520666200103115124","article-title":"New development of novel berberine derivatives against bacteria","volume":"20","author":"Jamshaid","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-020-2470-8","article-title":"Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.12.166","article-title":"Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats","volume":"325","author":"Huang","year":"2023","journal-title":"J Affect Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.08.003","article-title":"Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice","volume":"81","author":"Peng","year":"2007","journal-title":"Life Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2016.01.002","article-title":"Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice","volume":"614","author":"Shen","year":"2016","journal-title":"Neurosci Lett"},{"key":"B19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2015.68.3.220","article-title":"Standard deviation and standard error of the mean","volume":"68","author":"Lee","year":"2015","journal-title":"Korean J Anesthesiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41598-017-01035-5","article-title":"Berberine produces antidepressant-like effects in ovariectomized mice","volume":"7","author":"Fan","year":"2017","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2012.16.6.379","article-title":"Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats","volume":"16","author":"Lee","year":"2012","journal-title":"Korean J Physiol Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.05.043","article-title":"On the mechanism of antidepressant-like action of berberine chloride","volume":"589","author":"Kulkarni","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.002","article-title":"Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride","volume":"569","author":"Kulkarni","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13041-019-0518-4","article-title":"Proteomic profiling of the neurons in mice with depressive-like behavior induced by corticosterone and the regulation of berberine: pivotal sites of oxidative phosphorylation","volume":"12","author":"Gong","year":"2019","journal-title":"Mol Brain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/PM.PM_268_18","article-title":"Berberine protects against chronic social defeat stress-induced depressive-like behaviors with upregulation of neuronal PAS domain protein 4\/brain-derived neurotrophic factor signaling pathway","volume":"14","author":"Deng","year":"2018","journal-title":"Pharmacogn Magazine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1039\/C9BM02006C","article-title":"Intranasal delivery of berberine via in situ thermoresponsive hydrogels with non-invasive therapy exhibits better antidepressant-like effects","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"113764","DOI":"10.1016\/j.bbr.2022.113764","article-title":"Regulation of the kynurenine\/serotonin pathway by berberine and the underlying effect in the hippocampus of the chronic unpredictable mild stress mice","volume":"422","author":"Wang","year":"2022","journal-title":"Behav Brain Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6353","article-title":"Effects of berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays","volume":"15","author":"Zhu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"110808","DOI":"10.1016\/j.intimp.2023.110808","article-title":"Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65","volume":"123","author":"Yang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"116012","DOI":"10.1016\/j.biopha.2023.116012","article-title":"Berberine exerts antidepressant effects in vivo and in vitro through the PI3K\/AKT\/CREB\/BDNF signaling pathway","volume":"170","author":"Tang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chmed.2020.11.001","article-title":"Berberine exerts antidepressant-like effects via regulating miR-34a-synaptotagmin1\/Bcl-2 axis","volume":"13","author":"Yi","year":"2021","journal-title":"Chin Herb Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7616","article-title":"Berberine ameliorates depression-like behavior in CUMS mice by activating TPH1 and inhibiting IDO1-associated with tryptophan metabolism","volume":"37","author":"Ge","year":"2023","journal-title":"Phytother Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12974-023-02744-7","article-title":"Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption","volume":"20","author":"Qin","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.08.008","article-title":"Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice","volume":"134","author":"Liu","year":"2017","journal-title":"Brain Res Bull"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9970240","DOI":"10.1155\/2021\/9970240","article-title":"Exploring the mechanism of berberine intervention in ulcerative colitis from the perspective of inflammation and immunity based on systemic pharmacology","volume":"2021","author":"Jiang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2017.08.005","article-title":"Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action","volume":"141","author":"Eliwa","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S289444","article-title":"Berberine suppresses mice depression behaviors and promotes hippocampal neurons growth through regulating the miR-34b-5p\/miR-470-5p\/BDNF axis","volume":"17","author":"Zhan","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.12.017","article-title":"The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1653929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:24:15Z","timestamp":1767007455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1653929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":42,"alternative-id":["10.3389\/fpsyt.2025.1653929"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1653929","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"article-number":"1653929"}}